Lilly's Weight-Loss Wonder Zepbound Faces Reimbursement Hurdle with CVS Health
2025-05-01
The Associated Press
Eli Lilly's groundbreaking weight-loss medication, Zepbound, has been making waves in the pharmaceutical industry, but its success is now being threatened by a potential coverage challenge from CVS Health. As a result, the company's stock prices expe ...Read more
